Data presentation today at the liver meeting® 2021 shows increasing hospital admissions for alcohol-associated hepatitis (ah) in the u.s.

Cupertino, calif., nov. 12, 2021 /prnewswire/ -- durect corporation (nasdaq: drrx) today announced the presentation of data at the american association for the study of liver diseases (aasld) the liver meeting® 2021 showcasing an increase of hospitalizations for alcohol-associated hepatitis (ah) in the u.s. of approximately 19% (from 110,085 in 2015 to 131,510 in 2018) or approximately 4.8% per year between 2015 and 2018.
DRRX Ratings Summary
DRRX Quant Ranking